COMPARATIVE CHARACTERISTICS OF THE EFFECT OF ALPHA-LIPOIC ACID AND SODIUM AMINOPHTHALHYDROXIDE ON HEMATOLOGICAL PARAMETERS OF OLD RATS WITH EXPERIMENTAL DIABETES MELLITUS
- Authors: Sredneva L.A.1, Sultanova T.R.1
-
Affiliations:
- Institute of Immunology and Physiology, Ural Branch, Russian Academy of Science, Yekaterinburg, Russia
- Section: Immunological readings in Chelyabinsk
- Submitted: 25.03.2025
- Accepted: 31.05.2025
- URL: https://rusimmun.ru/jour/article/view/17135
- DOI: https://doi.org/10.46235/1028-7221-17135-CCO
- ID: 17135
Cite item
Full Text
Abstract
AbstractIntroduction. The elderly are a high-risk group for the development of diabetes mellitus (DM). Both aging and DM can influence hematological parameters, reflecting key physiological and pathological processes. The additive effect of aging and diabetes may exacerbate alterations in complete blood count parameters, leading to more pronounced hematological changes and an increased risk of complications. To mitigate pathological processes associated with DM, antioxidants and anti-inflammatory drugs are widely utilized. However, the effects of certain compounds, such as alpha-lipoic acid (ALA) and sodium aminodihydrophthalazinedione (APG), on blood parameters remain insufficiently investigated. The aim of this study was to evaluate and compare the effects of ALA and APG on biochemical and hematological parameters in aged rats with alloxan-induced DM. Materials and Methods. The study was conducted on 35 male Wistar rats, which were divided into five groups: 1 – young (5 months) intact animals, 2 – aged (18 months) intact animals, 3 – aged rats with DM, 4 – aged rats with DM treated with ALA, 5 – aged rats with DM treated with APG. Diabetes was induced by intraperitoneal administration of alloxan. ALA was administered intramuscularly to diabetic animals at a dose of 4 mg/100 g of body weight every other day for 30 days. APG was administered intramuscularly at a dose of 2 mg/100 g of body weight according to the following regimen: daily for 10 days, every other day for the next 5 days, and every third day for the remaining 15 days. On day 60, blood samples were collected to assess glycemic levels and hematological parameters. Results. Biochemical analysis revealed that both ALA and APG administration similarly corrected metabolic disturbances in diabetic rats, significantly reducing blood glucose levels. Hematological analysis showed an age-associated increase in red blood cell distribution width. Administration of ALA led to an increase in mean corpuscular volume and mean corpuscular hemoglobin, but a decrease in mean corpuscular hemoglobin concentration. In contrast, APG significantly increased red blood cell count, hemoglobin concentration, and hematocrit. Both agents significantly reduced the relative lymphocyte count and increased the relative granulocyte count. ALA and APG also reduced total platelet count, mean platelet volume, and platelet distribution width, while increasing plateletcrit. Conclusions. Administration of both ALA and APG alleviated hyperglycemia in rats with alloxan-induced diabetes by lowering blood glucose levels. Both compounds exerted similar effects on white blood cell and platelet parameters, however, they differed in their corrective effects on red blood cell indices in diabetic rats.
About the authors
Lyubov Alexandrovna Sredneva
Institute of Immunology and Physiology, Ural Branch, Russian Academy of Science, Yekaterinburg, Russia
Email: lyubabio44@gmail.com
ORCID iD: 0009-0000-7715-3986
Junior Researcher, Laboratory of Morphology and Biochemistry, Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences, Yekaterinburg, Russia
Russian Federation, 620049 Yekaterinburg, 106 Pervomayskaya St.Tatiana Rashidovna Sultanova
Institute of Immunology and Physiology, Ural Branch, Russian Academy of Science, Yekaterinburg, Russia
Author for correspondence.
Email: tatiana.sultanova.97@yandex.ru
Junior Researcher, Laboratory of Morphology and Biochemistry
Russian Federation, 620049 Yekaterinburg, 106 Pervomayskaya St.;References
- Абидов М.Т. Иммунотропная активность тамерита // Бюллетень экспериментальной биологии и медицины, 2000. Приложение 3. С. 11-19. Abidov M.T. Immunotropic activity of tamerit. Bulletin of Experimental Biology and Medicine, 2000, no. S3, pp. 11-19. (In Russ.)
- https://tamerit.com/sites/default/files/2024-03/%D0%A2%D0%B0%D0%BC%D0%B5%D1%80%D0%B8%D1%82_%D0%A1%D1%82%D0%B0%D1%82%D1%8C%D1%8F_%D0%B8_%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D1%87%D0%B0%D1%81%D1%82%D1%8C_1.pdf
- Булавинцева Т.С., Юшков Б.Г., Данилова И.Г., Абидов М.Т. Влияние макрофагов на инсулинсинтезирующую систему в норме и при аллоксановом диабете // Медицинская иммунология. – 2023. – Т. 25, № 2. – С. 287-300. Bulavintseva T.S., Yushkov B.G., Danilova I.G., Abidov M.T.
- Influence of macrophages on the insulin-synthesizing system
- under normal conditions and in alloxan diabetes. Meditsinskaya Immunologiya = Medical Immunology, 2023, Vol. 25, no. 2, pp. 287-300. (In Russ.) https://doi.org/10.15789/10.15789/1563-0625-IOM-2534
- Данилова И.Г., Гетте И.Ф., Булавинцева Т.С. Способ моделирования аллоксанового диабета. Патент РФ № 2534411.2014. Danilova I.G., Gette I.F., Bulavintseva T.S. Method for simulating alloxan diabetes. Patent RF, № 2534411, 2014. (in Russ) https://yandex.ru/patents/doc/RU2534411C1_20141127
- Емельянов В. В., Леонтьев Д. В., Ищенко А. В., Булавинцева Т. С., Саватеева Е. А., Данилова И. Г. Атомно-силовая микроскопия эритроцитов и метаболические нарушения при экспериментальном сахарном диабете и его коррекции липоевой кислотой. Биофизика. – 2016. – Т. 61, № 6. – С. 922-926. Emelyanov V. V., Leontiev D. V., Ishchenko A. V., Bu lavintseva T. S., Savateeva E. A., Danilova I. G. Atomic force microscopy of erythrocytes and metabolic dis orders in experimental diabetes mellitus and its cor rection with lipoic acid. Biofizika = Biophysics, 2016, Vol. 61, no. 6, pp. 922-926. (In Russ.) https://www.elibrary.ru/item.asp?id=27327343
- Abdel Hamid D.Z., Nienaa Y.A., Mostafa T.M. Alpha-lipoic acid improved anemia, erythropoietin resistance, maintained glycemic control, and reduced cardiovascular risk in diabetic patients on hemodialysis: a multi-center prospective randomized controlled study. Eur. Rev. Med. Pharmacol. Sci., 2022, Vol. 26, no. 7, pp. 2313-2329. https://doi.org/10.26355/eurrev_202204_
- Bambo, G. M., Asmelash, D., Alemayehu, E., Gedefie, A., Duguma, T., & Kebede, S. S. Changes in selected hematological parameters in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. Front. Med., 2024, Vol. 11, pp. 1294290. https://doi.org/10.3389/fmed.2024.1294290
- Farooqui R., Afsar N., Afroze, I.A. Role and Significance of Hematological parameters in Diabetes Mellitus. APALM, 2019, Vol. 6, no. 3, pp. A-158-A-162 https://doi.org/10.21276/APALM.2355
- GBD 2021 Diabetes Collaborators (Ong K.L., Stafford L.K., McLaughlin S.A., Boyko E.J., Vollset S.E.) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2023, Vol. 402, no. 10397, pp. 203-234. https://doi.org/10.1016/S0140-6736(23)01301-6
- Halim M., Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes & metabolic syndrome, 2019, Vol. 13, no. 2, pp. 1165-1172. https://doi.org/10.1016/j.dsx.2019.01.040
- Pathak B., Maimoon S. A Cross-Sectional Study of Hematological Parameters in the Geriatric Population Using Peripheral Smear Examination and a Five-Part Cell Counter. Cureus, 2024, Vol. 16, no. 4, pp. e57910. https://doi.org/10.7759/cureus.57910
- Singh P., Vijay P., Chandra S., Singh S.K., Singh D., Devi P. (2024). Demographics and Haematological Parameters in Patients with Type II Diabetes Mellitus in Uttar Pradesh – A Comparative study. IJDR, 2024, Vol. 35, no. 3, pp. 304-308. https://doi.org/10.4103/ijdr.ijdr_924_23
Supplementary files
